Non-imidazole histamine NO-donor H3-antagonists

Farmaco

Volumn 60, Issue 6-7, 2005, Pages 507-512

  Tosco, Paolo ^a   Bertinaria, Massimo ^a   Di Stilo, Antonella ^a   Cena, Clara ^a   Fruttero, Roberta ^a   Gasco, Alberto ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Furazans; Furoxans; H3 antagonists; Histamine; NO donors

Indexed keywords

A 923; ETHYL 4 [3 [4 (3 CYANOFUROXAN 4 YL)PHENOXY]PROPYL]PIPERAZINE 1 CARBOXYLATE; ETHYL 4 [3 [4 (3 METHYLFUROXAN 4 YL)PHENOXY]PROPYL]PIPERAZINE 1 CARBOXYLATE; ETHYL 4 [3 [4 (4 CYANOFURAZAN 3 YL)PHENOXY]PROPYL]PIPERAZINE 1 CARBOXYLATE; ETHYL 4 [3 [4 (4 METHYLFURAZAN 4 YL)PHENOXY]PROPYL]PIPERAZINE 1 CARBOXYLATE; ETHYL 4 [3 [4 [(3 AMINOCARBONYL)FUROXAN 4 YL]PHENOXY]PROPYL]PIPERAZINE 1 CARBOXYLATE; ETHYL 4 [3 [4 [(3 HYDROXYMETHYL)FUROXAN 4 YL]PHENOXY]PROPYL]PIPERAZINE 1 CARBOXYLATE; ETHYL 4 [3 [4 [(4 AMINOCARBONYL)FURAZAN 3 YL]PHENOXY]PROPYL]PIPERAZINE 1 CARBOXYLATE; ETHYL 4 [3 [4 [(4 HYDROXYMETHYL)FURAZAN 3 YL]PHENOXY]PROPYL]PIPERAZINE 1 CARBOXYLATE; HISTAMINE H3 RECEPTOR ANTAGONIST; NITRIC OXIDE DONOR; PIPERAZINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; DRUG ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; ELECTROSTIMULATION; GUINEA PIG; HYDROPHILICITY; ILEUM CONTRACTION; LIPOPHILICITY; MALE; NONHUMAN; RECEPTOR AFFINITY; SMOOTH MUSCLE RELAXATION; SUBSTITUTION REACTION;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; GUINEA PIGS; HISTAMINE AGONISTS; HISTAMINE ANTAGONISTS; ILEUM; IMIDAZOLES; MALE; METHYLHISTAMINES; MUSCLE RELAXATION; NITRIC OXIDE DONORS; OXADIAZOLES; PYRILAMINE; QUINOXALINES; RANITIDINE; RECEPTORS, HISTAMINE H3;

EID: 21744461467     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.farmac.2005.04.007     Document Type: Article

References (18)

1. 3-antagonists endowed with NO-donor properties Bioorg. Med. Chem. 12 2003 1197 1205
2. 3-antagonists Farmaco 59 2004 359 371
3. 3 receptor agonists and antagonists Trends Pharmacol. Sci. 19 1998 177 183
4. S.C. Gammie, V.L. Dawson, and R.J. Nelson Influence of nitric oxide on neuroendocrine function and behaviour L.J. Ignarro Nitric Oxide-Biology and Pathobiology 2000 Academic Press New York 429 438
5. 3-receptor ligands of the proxifan series: imoproxifan and other selective antagonists with high oral in vivo potency J. Med. Chem. 43 2000 3335 3343
6. 3-antagonist Imoproxifan and related furazan derivatives Bioorg. Med. Chem. 2005 in press
7. 3 receptor and its ligands Prog. Med. Chem. 38 2001 279 308
8. 3 receptor ligands. Part 1 Bioorg. Med. Chem. Lett. 12 2002 2031 2034
9. G. Sorba, C. Medana, R. Fruttero, C. Cena, A. Di Stilo, U. Galli, and A. Gasco Water soluble furoxan derivatives as NO prodrugs J. Med. Chem. 40 1997 463 469
10. a determination of water-insoluble compounds. Validation study in methanol/water mixtures Int. J. Pharm. 151 1997 235 248
11. A. Avdeef Difference plot for determining ion-pair octanol-water partition coefficients of multiprotic substances Quant. Struct.- Act. Relatsh. 11 1992 510 517
12. C. Hansch, J.P. Björkroth, and A. Leo Hydrophobicity and central nervous system agents: on the principle of minimal hydrophobicity in drug design J. Pharm. Sci. 76 1987 663 687
13. 3 ligands Meth. Find. Exp. Clin. Pharmacol. 105 1992 747 751
14. J.H. Gaddum Theories of drug antagonism Pharmacol. Rev. 9 1957 211 218
15. P.A. Barrett, A.G. Caldwell, and L.P. Walls 6-Methoxy-8-(ω- piperazin-1′-ylalkylamino)quinolines J. Chem. Soc. 1961 2404 2418
16. A. Avdeef Refinement of partition coefficients and ionization constants of multiprotic substances J. Pharm. Sci. 82 1993 183 190
17. a determination of water-insoluble substances Anal. Chem. 65 1993 42 49
18. A. Avdeef Assessment of distribution-pH profiles V. Pliska B. Testa H. van de Waterbeemd Lipophilicity in Drug Action and Toxicology 1996 VCH Publishers Weinheim 109 139